Difference between revisions of "Minutes - Medication WG 2022-05-24"
From Health Level 7 Belgium Wiki
KarlienErauw (talk | contribs) |
KarlienErauw (talk | contribs) |
||
| Line 37: | Line 37: | ||
* We have to complexities of contraindications and (drug) allergies & intolerances | * We have to complexities of contraindications and (drug) allergies & intolerances | ||
::* drug allergies & intolerances are related to decision support, therefore might not be needed to include in the medication scheme but offer as additional service | ::* drug allergies & intolerances are related to decision support, therefore might not be needed to include in the medication scheme but offer as additional service | ||
| − | ::* modelling of contraindications needs still to be determined, which can also be temporarily (f.e. pregnancy) | + | ::* modelling of contraindications needs still to be determined, which can also be temporarily (f.e. pregnancy, breastfeeding) |
::* allergy & intolerance will be the way to present this kind of info | ::* allergy & intolerance will be the way to present this kind of info | ||
| + | ::* there are 2 types for which distinction need to be made: patient related & drug related | ||
| + | ::* patient's condition is part of medical history (f.e. epilepsy) | ||
| − | ::* | + | * SAM viewer, there is VNP, CNK etc |
| − | * | + | ::* how many tables are there in the database ? |
| − | * | + | ::* this is the hierarchy: vmp-group > AMP > AMPP > CNK (old) |
| − | + | ::* concepts to be uses in MS will have to be defined | |
| − | + | ::::* f.e. support substances ? | |
| − | * | + | ::::* Jens will have a look |
'''Agenda items for next meeting''' | '''Agenda items for next meeting''' | ||
| − | * | + | * Current state of profiles on medication view and treatment lines and how it all works at operational level |
| + | * Review made changes | ||
| + | * Collect feedback on contraindications | ||
| + | * Identifying business rules | ||
'''Next meeting June 7 at 11AM''' | '''Next meeting June 7 at 11AM''' | ||
Latest revision as of 10:11, 24 May 2022
Attendees
- Bart Decuypere
- Jens Penny
- José Costa Teixeira
- Karlien Erauw
- Nick Hermans
- Pablo Christiaens
- Tom Henkens
Excused/Not present
- Anne Nerenhausen
- Annemieke Vergauwe
- Bruno Casneuf
- Dieter Sauvillers
- Elhassan Baazizi
- Hanne Vuegen
- Jan Lenie
- Jean-Louis Maggetto
- Jean-Michel Polfliet
- Katrien Thorré
- Lars Vanreppelen
- Marc Buckens
- Nick Hermans
- Nils Devos
- Richard Francken
- Thomas Van Langendonck
- Tom De Backer
- Walter Bollaert
- Will van Norel
Agenda
- Future of medication scheme
Minutes
- Work on business rules is ongoing based upon the use case, have to be part of the implementation guide
- We need some documentation for the migration from Kmehr to FHIR: input is needed
- We have to complexities of contraindications and (drug) allergies & intolerances
- drug allergies & intolerances are related to decision support, therefore might not be needed to include in the medication scheme but offer as additional service
- modelling of contraindications needs still to be determined, which can also be temporarily (f.e. pregnancy, breastfeeding)
- allergy & intolerance will be the way to present this kind of info
- there are 2 types for which distinction need to be made: patient related & drug related
- patient's condition is part of medical history (f.e. epilepsy)
- SAM viewer, there is VNP, CNK etc
- how many tables are there in the database ?
- this is the hierarchy: vmp-group > AMP > AMPP > CNK (old)
- concepts to be uses in MS will have to be defined
- f.e. support substances ?
- Jens will have a look
Agenda items for next meeting
- Current state of profiles on medication view and treatment lines and how it all works at operational level
- Review made changes
- Collect feedback on contraindications
- Identifying business rules
Next meeting June 7 at 11AM
